Role and Relevance of Neurocognitive Assessment in Clinical Trials of Patients With CNS Tumors

This publication has 25 references indexed in Scilit:

• Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma
  International Journal of Radiation Oncology*Biology*Physics, 2004
• Cognitive deficits in adult patients with brain tumours
  Published by Elsevier ,2004
• Neurocognitive Function and Progression in Patients With Brain Metastases Treated With Whole-Brain Radiation and Motexafin Gadolinium: Results of a Randomized Phase III Trial
  Journal of Clinical Oncology, 2004
• The Use of the Mini-Mental State Examination to Assess Cognitive Functioning in Cancer Trials: No Ifs, Ands, Buts, or Sensitivity
  Journal of Clinical Oncology, 2003
• Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant Glioma
  Journal of Clinical Oncology, 2000
• What do cancer patients mean when they complain of concentration and memory problems?
  British Journal of Cancer, 1996
• The functional assessment of cancer therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors
  Cancer, 1995
• Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores
  Journal of Neuro-Oncology, 1992
• Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials.
  Journal of Clinical Oncology, 1991
• Scientific problems in clinical scales, as demonstrated in the karnofsky index of performance status
  Journal of Chronic Diseases, 1979